These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35682939)

  • 1. Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway.
    AlAsmari AF; Alghamdi A; Ali N; Almeaikl MA; Hakami HM; Alyousef MK; AlSwayyed M; Alharbi M; Alqahtani F; Alasmari F; Alsaleh N
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML).
    Ando H; Murakami Y; Eshima K; Ishida T
    Cancer Rep (Hoboken); 2022 Mar; 5(3):e1485. PubMed ID: 34173723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis.
    Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L
    Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis.
    Jin S; Cojocari D; Purkal JJ; Popovic R; Talaty NN; Xiao Y; Solomon LR; Boghaert ER; Leverson JD; Phillips DC
    Clin Cancer Res; 2020 Jul; 26(13):3371-3383. PubMed ID: 32054729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
    Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
    J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
    Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E
    Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
    He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
    Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
    Asslaber D; Wacht N; Leisch M; Qi Y; Maeding N; Hufnagl C; Jansko B; Zaborsky N; Villunger A; Hartmann TN; Greil R; Egle A
    Clin Cancer Res; 2019 Mar; 25(6):1901-1912. PubMed ID: 30487125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
    Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
    Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na
    Liu X; Qiu Y; Huang N; Liu YH; Wang HH; Yu YN; Song YT; Wan GR; Wang SX; Li P; Yin YL
    J Biochem Mol Toxicol; 2022 Mar; 36(3):e22971. PubMed ID: 34813134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
    El-Said NT; Mohamed EA; Taha RA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro.
    Chu X; Zhang Y; Xue Y; Li Z; Shi J; Wang H; Chu L
    Int Immunopharmacol; 2020 Jul; 84():106548. PubMed ID: 32388215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
    Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
    Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis.
    Kuzu M; Kandemir FM; Yildirim S; Kucukler S; Caglayan C; Turk E
    Biomed Pharmacother; 2018 Oct; 106():443-453. PubMed ID: 29990832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
    Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
    Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
    Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
    Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
    Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation.
    El-Bakly WM; Louka ML; El-Halawany AM; Schaalan MF
    Cancer Chemother Pharmacol; 2012 Dec; 70(6):833-41. PubMed ID: 23014738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.